No specific antivirals are currently available for two emerging infectious diseases, Middle
East respiratory syndrome (MERS) and severe acute respiratory syndrome (SARS). A …

The advent of PCR has improved the identification of viruses in patients with community-
acquired pneumonia (CAP). Several studies have used PCR to establish the importance of …

Abstract Background Coronaviruses (CoVs) were long thought to only cause mild respiratory
and gastrointestinal symptoms in humans but outbreaks of Middle East Respiratory …

Community-acquired pneumonia (CAP) is an important respiratory disease and the fifth
leading cause of mortality in Europe. The development of molecular diagnostic tests has …

Background: The thiazolide nitazoxanide (NTZ) is a broad-spectrum antiinfective drug that
adversely affects viability, growth, and proliferation of a range of extracellular and …

Viruses account for more episodes of respiratory tract disease than any other microbial
pathogens, and exact a significant toll on society and healthcare systems, leading to …

Chronic respiratory diseases are among the leading causes of mortality worldwide, with the
major contributor, chronic obstructive pulmonary disease (COPD) accounting for …

Data from previous seasonal epidemics and pandemics have confirmed that pregnant
women are at increased risk for severe influenza virus infection. Complications including …

The mass gathering of people is a potential source for developing, propagating, and
disseminating infectious diseases on a global scale. Of the illnesses associated with mass …

Rhinosinusitis (RS) is a symptomatic disease classification of many causes and is a major
economic burden worldwide. It is widely accepted that RS is further classified into acute …